Outcome of Combined Temozolomide/CCNU versus Temozolomide (Standard or Extended) For Patients with Methylated MGMT Glioblastoma. J. Can. Res. Updates [Internet]. 2026 Jul. 15 [cited 2026 Jul. 16];15(3):197-205. Available from: https://mail.neoplasiaresearch.com/index.php/jcru/article/view/970